Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 10.30
-0.20 (-1.90%)
Aug 1, 2025, 2:59 PM CST
TPEX:4186 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 22.88 | -10.68 | 3.17 | -118.53 | -86.39 | Upgrade |
Depreciation & Amortization | 20.62 | 25.9 | 28.18 | 30.39 | 33.72 | Upgrade |
Loss (Gain) From Sale of Assets | 0.03 | -0.38 | -0.01 | 0.03 | -0.14 | Upgrade |
Asset Writedown & Restructuring Costs | - | 9.15 | 1.89 | 6.05 | - | Upgrade |
Loss (Gain) From Sale of Investments | 14.69 | 1.23 | -2.58 | -2.06 | -16.42 | Upgrade |
Provision & Write-off of Bad Debts | 3.58 | 1.84 | 0.79 | 0.1 | 6.48 | Upgrade |
Other Operating Activities | -1.15 | -0.99 | 0.23 | 5.78 | 5.34 | Upgrade |
Change in Accounts Receivable | -50.13 | 10.01 | 4.99 | -13.6 | -9.1 | Upgrade |
Change in Inventory | 3.06 | 2.48 | 0.21 | -0.41 | -0.39 | Upgrade |
Change in Accounts Payable | -1.26 | 0.3 | -0.81 | -2.32 | -1.43 | Upgrade |
Change in Unearned Revenue | 9.55 | 0.72 | -35.48 | 37.69 | 1.47 | Upgrade |
Change in Other Net Operating Assets | -13.54 | -26.96 | -21.18 | 8.8 | 16.53 | Upgrade |
Operating Cash Flow | 8.33 | 12.61 | -20.59 | -48.08 | -50.33 | Upgrade |
Operating Cash Flow Growth | -33.95% | - | - | - | - | Upgrade |
Capital Expenditures | -3.96 | -11.94 | -7.28 | -15.19 | -54.18 | Upgrade |
Sale of Property, Plant & Equipment | 0.26 | 1.4 | 1.16 | - | 0.76 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | -1.5 | Upgrade |
Investment in Securities | 0.29 | -1.8 | -3.01 | - | -0.51 | Upgrade |
Other Investing Activities | 1.19 | -1.36 | 0.3 | -0 | 0.98 | Upgrade |
Investing Cash Flow | -2.22 | -13.7 | -8.83 | -15.2 | -54.45 | Upgrade |
Short-Term Debt Issued | - | 49.06 | 23.09 | - | 18.06 | Upgrade |
Long-Term Debt Issued | - | 16 | 40 | 30.7 | 133.72 | Upgrade |
Total Debt Issued | - | 65.06 | 63.09 | 30.7 | 151.78 | Upgrade |
Short-Term Debt Repaid | -40 | - | - | -9.05 | - | Upgrade |
Long-Term Debt Repaid | -41.92 | -40.38 | -34.69 | -35.62 | -166.21 | Upgrade |
Total Debt Repaid | -81.92 | -40.38 | -34.69 | -44.67 | -166.21 | Upgrade |
Net Debt Issued (Repaid) | -81.92 | 24.67 | 28.39 | -13.97 | -14.43 | Upgrade |
Issuance of Common Stock | - | - | - | - | 250 | Upgrade |
Other Financing Activities | - | - | -0.11 | 0.05 | -0.16 | Upgrade |
Financing Cash Flow | -81.92 | 24.67 | 28.28 | -13.92 | 235.41 | Upgrade |
Net Cash Flow | -75.81 | 23.58 | -1.14 | -77.2 | 130.64 | Upgrade |
Free Cash Flow | 4.37 | 0.67 | -27.87 | -63.28 | -104.51 | Upgrade |
Free Cash Flow Growth | 554.72% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 1.23% | 0.21% | -8.76% | -26.00% | -44.36% | Upgrade |
Free Cash Flow Per Share | 0.05 | 0.01 | -0.31 | -0.70 | -1.29 | Upgrade |
Cash Interest Paid | 7.41 | 7.27 | 6.13 | 7.43 | 10.44 | Upgrade |
Cash Income Tax Paid | - | -0.01 | - | 0 | 0.01 | Upgrade |
Levered Free Cash Flow | -33.65 | 60.04 | -11.92 | -15.82 | -65.6 | Upgrade |
Unlevered Free Cash Flow | -29.01 | 64.6 | -8.09 | -11.17 | -59.07 | Upgrade |
Change in Net Working Capital | 71.46 | -49.12 | 33.75 | -37.87 | -15.68 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.